Found: 14
Select item for more details and to access through your institution.
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25332-w
- By:
- Publication type:
- Article
Treatment with Anti-HER2 Chimeric Antigen Receptor Tumor-Infiltrating Lymphocytes (CAR-TILs) Is Safe and Associated with Antitumor Efficacy in Mice and Companion Dogs.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 648, doi. 10.3390/cancers15030648
- By:
- Publication type:
- Article
A Fraction of CD8+ T Cells from Colorectal Liver Metastases Preferentially Repopulate Autologous Patient-Derived Xenograft Tumors as Tissue-Resident Memory T Cells.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2882, doi. 10.3390/cancers14122882
- By:
- Publication type:
- Article
The Microenvironment of Small Intestinal Neuroendocrine Tumours Contains Lymphocytes Capable of Recognition and Activation after Expansion.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4305, doi. 10.3390/cancers13174305
- By:
- Publication type:
- Article
Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases.
- Published in:
- eLife, 2024, p. 1, doi. 10.7554/eLife.91705
- By:
- Publication type:
- Article
"NFAT regulates the alternative splicing of Allograft Inflammatory Factor-1 gene: Role in neointima formation".
- Published in:
- FASEB Journal, 2008, v. 22, p. 49, doi. 10.1096/fasebj.22.2_supplement.49
- By:
- Publication type:
- Article
Inhibition of Ca<sup>2+</sup>-calcineurin/Nuclear Factor of Activated T- cells (NFAT) signaling reduces the expression of TRPCI but not TRPC6 in vascular smooth muscle.
- Published in:
- FASEB Journal, 2007, v. 21, n. 6, p. A1243, doi. 10.1096/fasebj.21.6.a1243-a
- By:
- Publication type:
- Article
Nuclear Factor of Activated T-Cells is involved in the regulation of osteopontin expression in vascular smooth muscle.
- Published in:
- FASEB Journal, 2007, v. 21, n. 6, p. A1243, doi. 10.1096/fasebj.21.6.a1243-a
- By:
- Publication type:
- Article
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 8, p. 1, doi. 10.1038/s41419-018-0865-6
- By:
- Publication type:
- Article
Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00786-z
- By:
- Publication type:
- Article
Mouse Genetics Suggests Cell-Context Dependency for Myc-Regulated Metabolic Enzymes during Tumorigenesis.
- Published in:
- PLoS Genetics, 2012, v. 8, n. 3, p. 1, doi. 10.1371/journal.pgen.1002573
- By:
- Publication type:
- Article
Molecular profiling of driver events in metastatic uveal melanoma.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-15606-0
- By:
- Publication type:
- Article